Routine Use of Prophylactic Antibiotics during Laparoscopic Cholecystectomy Does Not Reduce the Risk of Surgical Site Infections

Autor: Sadık Kiliçturgay, Ekrem Kaya, Yilmaz Ozen, Pinar Sarkut, Hikmet Aktas
Přispěvatelé: Uludağ Üniversitesi/Tıp Fakültesi/Genel Cerrahi Anabilim Dalı., Sarkut, Pınar, Özen, Yılmaz, Kaya, Ekrem, AAG-7319-2021
Rok vydání: 2017
Předmět:
Infection risk
Male
Conference Paper
Scoring system
Cephalosporin
Antibiotics
Cefazolin
Diabetes mellitus
0302 clinical medicine
Biliary colic
Infection prevention
Bile
Antiinfective agent
Controlled clinical trial
Aged
80 and over

Double blind procedure
Cholecystectomy
Laparoscopic

Operation duration
Randomized controlled trial
030220 oncology & carcinogenesis
Cefuroxime axetil
Medical history
030211 gastroenterology & hepatology
Surgical site infection
Human
Microbiology (medical)
medicine.medical_specialty
Efficacy
Gallbladder perforation
Gram negative bacterium
Major clinical study
Placebo
Microbiology
03 medical and health sciences
Laparoscopic
Humans
Surgical Wound Infection
Prophylactic antibiotics
Cholecystectomy
Aged
Bacterial growth
Pregnancy
Bacteria
Prophylaxis
Prevention
Gold standard
Very elderly
Surgical infection
medicine.disease
Postoperative complication
Length of stay
Pancreatitis
Surgery
Risk factor
Rare disease
Enterococcus faecium
Need
Bacterium
Postoperative infection
Cholelithiasis
Enterococcus faecalis
Antibiotic prophylaxis
Priority journal
Risk assessment
Antibiotic agent
Smoking
Preoperative period
Middle Aged
Anti-Bacterial Agents
Tissue culture
Infectious Diseases
Female
Surgical drainage
medicine.drug
Adult
Bacterium isolate
Antibiotic Prophylaxis
Surgical Infection
Adolescent
medicine.drug_class
Laparoscopic cholecystectomy
Young Adult
Double-Blind Method
Escherichia coli
Staphylococcus epidermidis
medicine
Obesity
Human tissue
Elective surgery
business.industry
Chronic cholecystitis
Staphylococcus haemolyticus
Acute cholecystitis
Drug efficacy
Isolation and purification
Statistics and numerical data
Risk reduction
business
Controlled study
Zdroj: Surgical Infections. 18:603-609
ISSN: 1557-8674
1096-2964
DOI: 10.1089/sur.2016.265
Popis: Bu çalışma, 22-24 Kasım 2012 tarihleri arasında İstanbul[Türkiye]’da düzenlenen 16. Annual Meeting of the European-Society-of-Surgery (ESS)’da bildiri olarak sunulmuştur. Background: Laparoscopic cholecystectomy (LC) is the gold standard for the treatment of symptomatic gallbladder stones. As infections are rare in uncomplicated LC, it is widely accepted that prophylactic antibiotics need not be administered, and guidelines do not support routine antibiotic prophylaxis during elective LC. However, routine antibiotic prophylaxis for elective LC is still popular in many clinical settings. We investigated this situation in our department. Method: This randomized double-blind controlled study included 570 patients who underwent LC between March 2007 and February 2010. The exclusion criteria were antibiotic intake before surgery, steroid treatment, and the presence of pancreatitis, cholangitis, obstructive jaundice, cephalosporin allergy, or pregnancy. The patients were randomized into three groups. Group 1 (n = 193) received physiologic saline as placebo, Group 2 (n = 191) received a first-generation cephalosporin (cefazolin; 1 g), and Group 3 (n = 186) received a second-generation cephalosporin (cefuroksim aksetil; 750mg). Bile and epigastric and umbilical port tissue samples were harvested for culture. All patients were observed until the end of the fourth week after surgery. Patient age, sex, weight, American Society of Anesthesiologists (ASA) score, diabetes mellitus, smoking history, history of biliary colic in the past month, length of the hospital stay before the operation, operational findings (acute or chronic cholecystitis), operation duration, use of drainage, type of prophylaxis administered if any, culture results, surgical site infection (SSI) development, and time to SSI development along with associated treatments were evaluated. Results: There was no statistically significant difference between the groups with respect to any of the demographic and clinical features analyzed in this study. The SSI rate was 1.2% in total, and in Groups 1, 2, and 3, it was 1.5%, 1.04%, and 1.07%, respectively. There was no statistical difference regarding SSI among the groups (p = 1.00). Superficial SSI was observed in all groups, and in all patients, the site of infection was the entrance to the epigastric port through which the gallbladder had been removed. Conclusions: Surgical site infection is rare after LC, and antibiotic prophylaxis does not appear to affect the outcome significantly. Moreover, factors such as positive bile cultures, history of biliary attack, ASA score, diabetes, obesity, and smoking do not have any effect on SSI development. Thus, we conclude that antibiotic prophylaxis is not needed for elective LC. European Soc Surgery
Databáze: OpenAIRE